Published 1989 | Version v1
Book

The development of [18F]cyclofoxy as a ligand for imaging opioid receptors in the CNS of conscious humans

Description

Positron emission tomography (PET) is a unique, noninvasive technique applicable to real time visualization and quantitation of drug receptor occupancy in the brain of conscious humans. Such studies with the normal and abnormal human CNS can potentially provide insight into the biochemical basis of disease states and the effects of drug therapy. The (-)-enantiomer of cyclofoxy, a fluorinated, potent narcotic antagonist derived from naltrexone, has been developed at NIH as an agent for study of the opioid receptor-endorphin system using PET. The development and current status of this program is described, including application of the NIH Opiate Total Synthesis for production the pharmacologically inert (+)-[18F]cyclofoxy required for quantitation of receptor occupancy

Additional details

Publishing Information

Publisher
American Chemical Society.
Imprint Place
Washington, DC (USA)
Imprint Title
The 1989 international chemical congress of Pacific Basin Societies: Abstracts of papers, Parts I and II
Imprint Pagination
1700 p.
Journal Page Range
p. 1100, Paper ORGN 595.

Conference

Title
International chemical congress of Pacific Basin Societies (PACIFICHEM '89).
Dates
17-22 Dec 1989.
Place
Honolulu, HI (USA).

Optional Information

Secondary number(s)
CONF-891206--.